» Articles » PMID: 18767886

Photothermal Optical Coherence Tomography of Epidermal Growth Factor Receptor in Live Cells Using Immunotargeted Gold Nanospheres

Overview
Journal Nano Lett
Specialty Biotechnology
Date 2008 Sep 5
PMID 18767886
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Molecular imaging is a powerful tool for investigating disease processes and potential therapies in both in vivo and in vitro systems. However, high resolution molecular imaging has been limited to relatively shallow penetration depths that can be accessed with microscopy. Optical coherence tomography (OCT) is an optical analogue to ultrasound with relatively good penetration depth (1-2 mm) and resolution (approximately 1-10 microm). We have developed and characterized photothermal OCT as a molecular contrast mechanism that allows for high resolution molecular imaging at deeper penetration depths than microscopy. Our photothermal system consists of an amplitude-modulated heating beam that spatially overlaps with the focused spot of the sample arm of a spectral-domain OCT microscope. Validation experiments in tissuelike phantoms containing gold nanospheres that absorb at 532 nm revealed a sensitivity of 14 ppm nanospheres (weight/weight) in a tissuelike environment. The nanospheres were then conjugated to anti-EGFR, and molecular targeting was confirmed in cells that overexpress EGFR (MDA-MB-468) and cells that express low levels of EGFR (MDA-MB-435). Molecular imaging in three-dimensional tissue constructs was confirmed with a significantly lower photothermal signal (p<0.0001) from the constructs composed of cells that express low levels of EGFR compared to the overexpressing cell constructs (300% signal increase). This technique could potentially augment confocal and multiphoton microscopy as a method for deep-tissue, depth-resolved molecular imaging with relatively high resolution and target sensitivity, without photobleaching or cytotoxicity.

Citing Articles

Artificial neural network for enhancing signal-to-noise ratio and contrast in photothermal optical coherence tomography.

Salimi M, Tabatabaei N, Villiger M Sci Rep. 2024; 14(1):10264.

PMID: 38704427 PMC: 11069506. DOI: 10.1038/s41598-024-60682-7.


Photothermal optical coherence tomography for 3D live cell detection and mapping.

Sun J, Fang T, Wang H, Wang S Opt Contin. 2024; 2(12):2468-2483.

PMID: 38665863 PMC: 11044816. DOI: 10.1364/optcon.503577.


Plasmonic Nanoparticle-Enhanced Optical Techniques for Cancer Biomarker Sensing.

Fu L, Lin C, Karimi-Maleh H, Chen F, Zhao S Biosensors (Basel). 2023; 13(11).

PMID: 37998152 PMC: 10669140. DOI: 10.3390/bios13110977.


Gold nanomaterials for optical biosensing and bioimaging.

Si P, Razmi N, Nur O, Solanki S, Pandey C, Gupta R Nanoscale Adv. 2022; 3(10):2679-2698.

PMID: 36134176 PMC: 9418567. DOI: 10.1039/d0na00961j.


Three-dimensional opto-thermo-mechanical model for predicting photo-thermal optical coherence tomography responses in multilayer geometries.

Salimi M, Villiger M, Tabatabaei N Biomed Opt Express. 2022; 13(6):3416-3433.

PMID: 35781956 PMC: 9208589. DOI: 10.1364/BOE.454491.


References
1.
Seewaldt V, JOHNSON B, Parker M, Collins S, Swisshelm K . Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ. 1995; 6(9):1077-88. View

2.
Boyer D, Tamarat P, Maali A, Lounis B, Orrit M . Photothermal imaging of nanometer-sized metal particles among scatterers. Science. 2002; 297(5584):1160-3. DOI: 10.1126/science.1073765. View

3.
Xu C, Ye J, Marks D, Boppart S . Near-infrared dyes as contrast-enhancing agents for spectroscopic optical coherence tomography. Opt Lett. 2004; 29(14):1647-9. DOI: 10.1364/ol.29.001647. View

4.
Zharov V, Galanzha E, Tuchin V . Integrated photothermal flow cytometry in vivo. J Biomed Opt. 2005; 10(5):051502. DOI: 10.1117/1.2070167. View

5.
Yang C, Choma M, Lamb L, Simon J, Izatt J . Protein-based molecular contrast optical coherence tomography with phytochrome as the contrast agent. Opt Lett. 2004; 29(12):1396-8. DOI: 10.1364/ol.29.001396. View